Alwin D. R. Huitema
- Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology
2017/07/12 by Remy B. Verheijen, Huixin Yu, Jan H.M. Schellens +4 · 29 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Chronic Myeloid Leukemia Treatments #Chronic Lymphocytic Leukemia Research #PI3K/AKT/mTOR signaling in cancer
- Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
2010/07/08 by Ron J. Keizer, Alwin D. R. Huitema, Alwin D.R. Huitema +2 · 2 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Monoclonal and Polyclonal Antibodies Research #Protein purification and stability #Pharmaceutical studies and practices
- Piraña and PCluster: A modeling environment and cluster infrastructure for NONMEM
2010/06/03 by Ron J. Keizer, Michel van Benten, Jos H. Beijnen +3 · 1 citation
Chemistry · Engineering · Medicine · #Advanced MRI Techniques and Applications #Analytical Chemistry and Chromatography #Microfluidic and Capillary Electrophoresis Applications
- Pharmacokinetics and Pharmacodynamics of PARP Inhibitors in Oncology
2022/10/11 by Maaike A. C. Bruin, Gabe S. Sonke, Jos H. Beijnen +1 · 2 citations
Medicine · #PARP inhibition in cancer therapy
- Clinical Pharmacokinetics and Pharmacodynamics of the Cyclin-Dependent Kinase 4 and 6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib
2020/10/08 by Stefanie L. Groenland, Alejandra Martínez-Chávez, Marloes G. J. van Dongen +4 · 1 citation
Medicine · #Advanced Breast Cancer Therapies #Cancer-related Molecular Pathways #Chronic Lymphocytic Leukemia Research
- Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology
2023/08/16 by Maud B. A. van der Kleij, Niels A. D. Guchelaar, Niels A.D. Guchelaar +7 · 1 citation
Medicine · #Advanced Breast Cancer Therapies #Chronic Lymphocytic Leukemia Research #Chronic Myeloid Leukemia Treatments
- Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation
2026/07/27 by Jen-Hao Wu, Francisco Bautista, Erica Brivio +25